ARCHIVES

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

In Brief: Pagano to Retire As Lineberger Director; Nursing Society Elects Yarbro As President

September 20, 1996

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004